title: Organ markets and the ends of medicine.
abstract: As the gap between the need for and supply of human organs continues to widen, the aim of securing additional sources of these "gifts of the body" has become a seemingly overriding moral imperative, one that could-and some argue, should-override the widespread ban on organ markets. As a medical practice, organ transplantation entails the inherent risk that one human being, a donor, will become little more than a means to the end of healing for another human being and that he or she will come to have a purely instrumental value. With the establishment of organ markets, not only will the harms of instrumentalization be a reality-the ends of medicine will be further compromised and confused.
authors.affiliation: Center for Clinical Bioethics, Georgetown University, Washington, DC, USA. fdanieldavis@gmail.com
authors.forename: F Daniel
authors.initials: FD
authors.lastname: Davis
authors.forename: Samuel J
authors.initials: SJ
authors.lastname: Crowe
mesh_terms: D003132:Commerce / Q000941:ethics*; D006262:Health; D006801:Humans; D019520:Living Donors / Q000941:ethics* / Q000523:psychology; D026684:Personal Autonomy; D010686:Philosophy, Medical; D014019:Tissue Donors / Q000600:supply & distribution; D009927:Tissue and Organ Procurement / Q000191:economics / Q000941:ethics* / Q000458:organization & administration